# ChemAI - Quick Reference: What's Done & What's Left

## üéØ At a Glance

| Role | Component | Status | Completion |
|------|-----------|--------|-----------|
| **Pranay** | Problem Formalization | ‚úÖ Mostly Done | 80% |
| **Pranay** | System Architecture | ‚úÖ Implemented | 100% |
| **Pranay** | Research Documentation | ‚ùå Missing | 0% |
| **Vishwa** | ChEMBL Integration | ‚úÖ Complete | 100% |
| **Vishwa** | SMILES & Fingerprints | ‚úÖ Complete | 100% |
| **Vishwa** | Molecular Properties | ‚úÖ Complete | 100% |
| **Vishwa** | Graph Representation | ‚ö†Ô∏è Partial | 20% |
| **Vishwa** | Multi-Dataset Support | ‚ùå Missing | 0% |
| **Shreya** | Knowledge Graph | ‚ùå **MISSING** | **5%** |
| **Shreya** | Graph Algorithms | ‚ùå Missing | 0% |
| **Shreya** | Graph Embeddings | ‚ùå Missing | 0% |
| **Shreya** | Biological Integration | ‚ùå Missing | 0% |

---

## ‚úÖ WHAT'S BEEN COMPLETED (Current Implementation)

### Architecture & Pipeline
- [x] 5 specialized AI agents working together
- [x] Discovery pipeline: Generate ‚Üí Predict ‚Üí Rank ‚Üí Optimize
- [x] Genetic algorithm-based molecule generation
- [x] Multi-generation evolution strategy
- [x] Feedback loops for iterative improvement

### Machine Learning Models (All Trained & Working)
- [x] **Bioactivity Model** - Predicts pIC50 (drug potency)
- [x] **Property Model** - Predicts 7 molecular properties (MW, LogP, HBD, HBA, PSA, RotBonds, Aromatic_Rings)
- [x] **Toxicity Model** - Detects structural alerts & safety risks
- [x] **Drug-Likeness Model** - Predicts QED scores & drug-likeness classification

### Data & Features
- [x] ChEMBL v36 database integrated (~50K molecules for training)
- [x] SMILES canonicalization & validation
- [x] Morgan fingerprints (2048-bit, radius 2)
- [x] Lipinski's Rule of 5 compliance checking
- [x] PAINS filter implementation
- [x] Dataset balancing & cleaning
- [x] Statistical analysis of molecular properties

### Testing & Validation
- [x] 6 comprehensive test modules
- [x] 35+ performance metrics
- [x] HTML report generation
- [x] Advanced metrics calculator
- [x] Model performance dashboards

### Documentation
- [x] 9 documentation files (2000+ lines)
- [x] Installation guide
- [x] Testing framework reference
- [x] Quick reference guides

---

## ‚ùå WHAT'S MISSING (Critical Gaps)

### 1. Knowledge Graph (CRITICAL - 0% Done)
**Why it matters**: Without this, the system cannot reason about WHY molecules are good/bad

- [ ] **No formal knowledge graph** (Neo4j, RDF, or property graph)
- [ ] **Missing biological context**:
  - No protein-target information structures
  - No pathway database integration
  - No disease associations
  - No gene ontologies
  - No protein interaction networks
  
- [ ] **Cannot answer**:
  - "What mechanism explains this prediction?"
  - "What diseases can this molecule treat?"
  - "What off-target effects might it have?"
  - "Can this treat disease X better than current drugs?"

### 2. Graph Representations for ML (20% Done)
- [ ] Node features not pre-computed (atom type, charge, valency, etc.)
- [ ] Edge features not pre-computed (bond type, aromaticity, etc.)
- [ ] Graph adjacency matrices not stored
- [ ] GNN-compatible format not created
- [ ] **Impact**: Can't use Graph Neural Networks (state-of-the-art for molecules)

### 3. Advanced Features (0% Done)
- [ ] No graph convolutional features
- [ ] No 3D molecular descriptors
- [ ] No extended fingerprints (ECFP)
- [ ] No topological descriptors
- [ ] **Impact**: Limited molecular understanding

### 4. Multi-Dataset Support (0% Done)
- [ ] No QM9 dataset (quantum mechanical properties)
- [ ] No ZINC database (100M+ drug-like compounds)
- [ ] Only ChEMBL used (biased towards known drugs)
- [ ] **Impact**: Limited chemical diversity exploration

### 5. Graph Algorithms (0% Done)
- [ ] No shortest path algorithms (for drug repurposing)
- [ ] No community detection (for disease modules)
- [ ] No centrality measures (for target prioritization)
- [ ] No multi-hop reasoning
- [ ] **Impact**: Cannot discover novel therapeutic opportunities

### 6. Graph Embeddings (0% Done)
- [ ] No Node2Vec
- [ ] No DeepWalk
- [ ] No TransE knowledge graph embeddings
- [ ] **Impact**: Cannot leverage embeddings for similarity search or new predictions

### 7. Causal Reasoning (0% Done)
- [ ] No causal graphs
- [ ] No do-calculus
- [ ] No intervention simulation
- [ ] No counterfactual reasoning
- [ ] **Impact**: Cannot understand CAUSALITY, only correlation

### 8. Research Documentation (0% Done)
- [ ] No literature review (50+ citations needed)
- [ ] No gap analysis vs. existing systems
- [ ] No formal research paper/thesis structure
- [ ] No experimental design document
- [ ] No success criteria definition
- [ ] **Impact**: Cannot publish or defend research

---

## üìä Work Breakdown by Role

### PRANAY - Literature & Problem Formalization

**DONE (80%):**
- ‚úÖ Problem clearly stated
- ‚úÖ System architecture designed
- ‚úÖ 5 agents implemented
- ‚úÖ Agentic loop working
- ‚úÖ Basic research questions identified

**TODO (20%):**
- [ ] Formal literature review (with 50+ citations)
  - Molecular generation methods survey
  - RL in chemistry literature
  - Agentic systems comparison
  - Existing autonomous discovery systems

- [ ] Research gap analysis
  - What makes THIS system different?
  - What existing approaches lack?
  - Innovation claims

- [ ] Formal hypotheses
  - H1: Can agents discover drugs better than baseline?
  - H2: Does multi-generation improve diversity?
  - H3: Can causal reasoning improve predictions?

- [ ] Causal reasoning framework
  - Current system uses correlation only
  - Need to add causal inference layer

**Estimated effort**: 1-2 weeks

---

### VISHWA - Molecular Dataset Preparation & Feature Engineering

**DONE (70%):**
- ‚úÖ ChEMBL v36 database loaded
- ‚úÖ SMILES validation & canonicalization
- ‚úÖ Morgan fingerprints (2048-bit)
- ‚úÖ 7 molecular properties computed
- ‚úÖ Bioactivity (pIC50) preprocessing
- ‚úÖ Drug-likeness classification
- ‚úÖ Toxicity alert detection
- ‚úÖ Dataset balancing & cleaning
- ‚úÖ Statistical analysis
- ‚úÖ ~50K molecules for training

**TODO (30%):**
- [ ] Graph features pre-computation
  - Adjacency matrices
  - Node degree
  - Atom type vectors
  - Bond type vectors
  - Aromaticity flags

- [ ] Multi-dataset support
  - [ ] Integrate QM9 (111K molecules, quantum properties)
  - [ ] Integrate ZINC (100M molecules, diversity)
  - [ ] Handle different formats

- [ ] Advanced descriptors
  - [ ] Topological descriptors (Wiener, Randic indices)
  - [ ] 3D molecular geometry (conformer generation)
  - [ ] Extended fingerprints (ECFP)

- [ ] Feature quality metrics
  - [ ] Feature importance ranking
  - [ ] Correlation analysis
  - [ ] Permutation importance
  - [ ] Feature selection strategies

- [ ] Data quality report
  - [ ] Distribution plots
  - [ ] Outlier analysis
  - [ ] Benchmark vs. literature

**Estimated effort**: 2-3 weeks

---

### SHREYA - Knowledge Graph Construction (CRITICAL!)

**DONE (5%):**
- ‚úÖ ChEMBL data accessible (drug-target interactions exist in DB)
- ‚úÖ Bioactivity data connected (pIC50 predictions available)
- ‚úÖ Toxicity data available (structural alerts)

**TODO (95%) - CRITICAL WORK:**

1. **Graph Structure Definition** (Week 1)
   - [ ] Choose technology: Neo4j vs. RDF vs. Property Graph vs. Relational+JSON
   - [ ] Define node types:
     - Molecules (compounds)
     - Proteins/Targets
     - Pathways
     - Diseases
     - Genes
     - Side Effects
   - [ ] Define relationship types:
     - molecule-targets
     - protein-pathway
     - pathway-disease
     - gene-protein
     - target-disease

2. **Data Integration Pipeline** (Week 1-2)
   - [ ] Load ChEMBL molecules ‚Üí nodes
   - [ ] Load drug-target interactions ‚Üí edges
   - [ ] Integrate pathway databases (KEGG, Reactome)
   - [ ] Add disease associations
   - [ ] Add gene ontologies
   - [ ] Add side effect data (SIDER)

3. **Graph Algorithms** (Week 2-3)
   - [ ] Shortest path (for repurposing detection)
   - [ ] Centrality measures (for target prioritization)
   - [ ] Community detection (for disease modules)
   - [ ] Weighted paths (confidence-based reasoning)

4. **Embedding Methods** (Week 3)
   - [ ] Node2Vec for molecule similarity
   - [ ] DeepWalk for unsupervised learning
   - [ ] TransE for knowledge graph completion
   - [ ] Use embeddings for link prediction

5. **Reasoning Capabilities** (Week 4)
   - [ ] Multi-hop path queries
   - [ ] Constraint satisfaction
   - [ ] Conflict resolution
   - [ ] Uncertainty handling

6. **Causal Integration** (Week 4-5)
   - [ ] Build causal DAGs
   - [ ] Implement do-calculus
   - [ ] Intervention simulation
   - [ ] Counterfactual reasoning

**Estimated effort**: 4-5 weeks (HIGHEST PRIORITY)

---

## üö® Critical Path Items

### Must Have (Blocking other work):
1. **Knowledge Graph Structure** ‚Üí Shreya (1 week)
2. **Graph Data Loading** ‚Üí Shreya (1 week)
3. **Graph Embedding Methods** ‚Üí Shreya (1 week)

### Should Have (Important for research):
4. **Literature Review** ‚Üí Pranay (1 week)
5. **Advanced Features** ‚Üí Vishwa (1 week)
6. **Multi-Dataset Support** ‚Üí Vishwa (1 week)

### Nice to Have (Polish):
7. **Causal Reasoning** ‚Üí Shreya/Pranay (2 weeks)
8. **Complete Documentation** ‚Üí All (1 week)

---

## üìà Success Metrics

### Pranay Success Criteria:
- [ ] Research paper with 50+ citations
- [ ] Clear hypothesis statements
- [ ] Baseline comparisons to 3+ existing systems
- [ ] Expected performance targets

### Vishwa Success Criteria:
- [ ] Feature importance ranking available
- [ ] QM9 and ZINC datasets loaded
- [ ] Graph features pre-computed
- [ ] 15+ descriptors implemented
- [ ] Statistical report generated

### Shreya Success Criteria:
- [ ] Knowledge graph with 10K+ nodes operational
- [ ] 5+ node types, 8+ edge types
- [ ] Graph queries returning meaningful results
- [ ] Embedding-based similarity search working
- [ ] Path-based reasoning answering drug repurposing questions

---

## üîß Current System Limitations

| Limitation | Impact | Priority Fix |
|-----------|--------|--------------|
| No knowledge graph | Cannot reason about MOA, disease, side effects | CRITICAL |
| Fingerprints only | Not using state-of-the-art GNNs | HIGH |
| Single dataset | Limited chemical diversity | HIGH |
| Correlation not causation | Cannot explain predictions | HIGH |
| No uncertainty | Risky for drug discovery | MEDIUM |
| No 3D features | Missing important geometry info | MEDIUM |

---

## üìö Key Files to Modify/Create

**For Shreya (Graph Work):**
- [ ] `graph_db/graph_builder.py` - New file for knowledge graph construction
- [ ] `graph_db/graph_queries.py` - New file for reasoning queries
- [ ] `graph_db/embeddings.py` - New file for graph embeddings
- [ ] `agents/knowledge_agent.py` - New agent for graph-based reasoning

**For Vishwa (Advanced Features):**
- [ ] `models/graph_feature_engineer.py` - New file for graph features
- [ ] `models/descriptors.py` - New file for advanced descriptors
- [ ] `data/multi_dataset_loader.py` - New file for QM9/ZINC loading

**For Pranay (Documentation):**
- [ ] `research/literature_review.md` - New research document
- [ ] `research/hypotheses.md` - New hypothesis document
- [ ] `research/experimental_design.md` - New design document

---

## Timeline to Full System

```
Week 1:   Knowledge Graph Structure + Basic Loading [Shreya]
Week 2:   Graph Algorithms + Literature Review [Shreya + Pranay]
Week 3:   Graph Embeddings + Advanced Features [Shreya + Vishwa]
Week 4:   Multi-Dataset Support + Causal Framework [Vishwa + Pranay]
Week 5:   Integration Testing + Documentation [All]
Week 6:   Validation & Benchmarking [All]
Week 7:   Final Documentation & Publication Ready [All]
```

**Total: 7 weeks to production-ready AI-driven drug discovery system**

---

## Conclusion

‚úÖ **System Core**: Solid and working
‚ùå **Knowledge Representation**: Critical gap - knowledge graph needed
‚ö†Ô∏è **Feature Engineering**: Good but incomplete - needs graph features
üìù **Research Documentation**: Not started - needs formal structure

**Next action**: Start with Shreya on knowledge graph construction immediately.

